Drugs Medical Pharma

Treeline Biosciences discloses $421 million financing in latest filings

HQ Team October 19, 2024: Stealth startup Treeline Biosciences has raised another $421 million, one of the biggest raises of the year in.

Read More
Climate Health Pharma

Spraying diamond dust in atmosphere can stem global warming: Study

HQ Team  October 18, 2024: As global greenhouse gas emissions continue to rise there is an urgency to find effective climate intervention solutions..

Read More
Drugs Health Pharma

Sanofi to invest $324m in entity with Orano Med for radioligand therapy

Sanofi and Orano Med agreed to form a new entity, valued at 1.9 billion euros ($2.06 billion), to develop radioligand medicines and the.

Read More
Climate Drugs Pharma

China boosts emergency food supply in response to climate events

HQ Team October 17, 2024: Extreme weather conditions and the increasing number of natural disaster events have forced China to take steps to.

Read More
Drugs Medical Pharma

USFDA puts on hold influenza, Covid-19 trial vaccines of Novavax

Novavax, Inc.’s mid-stage trials on a combination of Covid-19 and influenza and a standalone influenza vaccine have been put on hold by the.

Read More
Climate Health Pharma

European body to teach medical students health risks from climate change

Twenty-four European universities have formed a network to impart skills to 10,000 medical students across undergraduate degree programmes to address current and future.

Read More
Drugs Medical Pharma

Coronary drug-eluting stent market to grow 4% in India till 2033: Report

India’s coronary drug-eluting stent market may grow at a compound annual growth rate of 4% until 2033 on the back of a rise.

Read More
Health Medical Opinion Pharma

Opinion: Casual mental health words spicing up normal chats not justifiable

By Aparna S October 16, 2024: Is it okay to use mental health words casually in everyday conversations? If you believe that this.

Read More
Drugs Health Pharma

Lundbeck targets epileptic drug, to buy Longboard for $2.6 billion

H. Lundbeck A/S, a Danish drugmaker, plans to acquire California, US-based Longboard Pharmaceuticals for $2.6 billion, giving it access to a late-stage drug.

Read More
Drugs Health Pharma

Pandemic threat looms, nations unprepared to handle crisis: WHO

Seventeen dangerous disease outbreaks, such as the Marburg virus and the latest strain of avian influenza this year, have increased the likelihood of.

Read More